Stock listing

gettex:TG40 Oxurion NV Aktie

German listing (gettex) of Oxurion NV · home listing Euronext:OXUR

Follow Oxurion NV into a list and get an email when it puts out news.

Home listing price · EURONEXT:OXUR

€0.0010 EUR 0.0000 (0.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:OXUR

Past year -90.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€0.0010 – €0.0014 EURNov 20, 2026
Volume
4.58M sharesNov 20, 2026
Market cap
€232,005 EURAt the close on Nov 20, 2026 · price × 232.0M shares outstanding
52-week range
€0.0006 – €0.0118 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€3,102 EURMedian day 688,163 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Oxurion NV logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:OXUR · Home€0.0010 EUR0.0000 (0.0%)4,575,649€0.0010€0.0014€0.0010€0.0010Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:OXUR · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.00100.00000.0%€0.0010€0.0014€0.00104,575,649
€0.0010+0.0002+25.0%€0.0008€0.0012€0.000812,461,813
€0.0008+0.0002+33.3%€0.0008€0.0008€0.00063,475,558
€0.0006-0.0002-25.0%€0.0006€0.0008€0.00061,050,429
€0.0008+0.0002+33.3%€0.0008€0.0008€0.0006688,163
€0.0006-0.0002-25.0%€0.0008€0.0010€0.00065,333,812
€0.00080.00000.0%€0.0008€0.0008€0.00063,690,709
€0.00080.00000.0%€0.0008€0.0008€0.0006290,164
€0.00080.00000.0%€0.0008€0.0008€0.00062,540,867
€0.00080.00000.0%€0.0008€0.0008€0.00066,942,060
€0.00080.00000.0%€0.0008€0.0008€0.00061,257,066
€0.00080.00000.0%€0.0008€0.0008€0.0006195,525
€0.0008+0.0002+33.3%€0.0008€0.0008€0.000612,331,414
€0.0006-0.0002-25.0%€0.0008€0.0008€0.00069,120
€0.00080.00000.0%€0.0008€0.0008€0.0008941,000
€0.0008+0.0002+33.3%€0.0008€0.0010€0.000820,320,212
€0.00060.00000.0%€0.0008€0.0008€0.00061,183,577
€0.0006-0.0002-25.0%€0.0008€0.0008€0.0006515,638
€0.00080.00000.0%€0.0008€0.0008€0.0008116,500
€0.00080.00000.0%€0.0008€0.0008€0.0008116,500
€0.00080.00000.0%€0.0008€0.0008€0.00064,046,200
€0.00080.00000.0%€0.0006€0.0008€0.0006349,555
€0.0008+0.0002+33.3%€0.0008€0.0008€0.0006350,356
€0.0006-0.0004-40.0%€0.0010€0.0010€0.000617,321,410
€0.0010+0.0002+25.0%€0.0010€0.0010€0.0010146,690
€0.00080.00000.0%€0.0010€0.0010€0.0008115,001
€0.00080.00000.0%€0.0010€0.0010€0.0008260,234
€0.0008-0.0002-20.0%€0.0010€0.0010€0.0008303,996
€0.00100.00000.0%€0.0010€0.0010€0.0008183,000
€0.0010-0.0002-16.7%€0.0012€0.0012€0.0008735,950
€0.00120.00000.0%€0.0012€0.0012€0.00081,631,383
€0.00120.00000.0%€0.0012€0.0012€0.0010517,029
€0.0012+0.0002+20.0%€0.0012€0.0012€0.00101,275,586
€0.00100.00000.0%€0.0012€0.0012€0.00109,731,721
€0.0010-0.0006-37.5%€0.0012€0.0012€0.001021,836,869
€0.00160.00000.0%€0.0012€0.0016€0.0012136,344
€0.0016+0.0002+14.3%€0.0012€0.0016€0.00121,440,276
€0.0014+0.0002+16.7%€0.0012€0.0016€0.0012742,283
€0.0012-0.0006-33.3%€0.0016€0.0018€0.00126,322,878
€0.00180.00000.0%€0.0018€0.0018€0.0014159,399
€0.00180.00000.0%€0.0016€0.0018€0.00142,757,034
€0.0018+0.0002+12.5%€0.0020€0.0020€0.00162,279,496
€0.0016-0.0002-11.1%€0.0022€0.0022€0.00163,216,867
€0.00180.00000.0%€0.0020€0.0026€0.00187,819,121
€0.0018-0.0004-18.2%€0.0028€0.0028€0.00185,376,678
€0.0022-0.0006-21.4%€0.0026€0.0026€0.00203,384,344
€0.00280.00000.0%€0.0028€0.0028€0.0024245,800
€0.0028+0.0004+16.7%€0.0026€0.0028€0.002641,666
€0.0024-0.0002-7.7%€0.0026€0.0026€0.00242,200
€0.00260.00000.0%€0.0024€0.0026€0.0024112,829
€0.0026+0.0002+8.3%€0.0024€0.0026€0.002413,302
€0.0024-0.0002-7.7%€0.0026€0.0026€0.0024117,970
€0.0026-0.0002-7.1%€0.0024€0.0026€0.00241,158,950
€0.00280.00000.0%€0.0028€0.0028€0.00243,185,125
€0.0028+0.0002+7.7%€0.0026€0.0028€0.002667,002
€0.00260.00000.0%€0.0028€0.0028€0.00261,640
€0.00260.00000.0%€0.0026€0.0028€0.0026360,234
€0.00260.00000.0%€0.0026€0.0026€0.0026158,176
€0.00260.00000.0%€0.0030€0.0030€0.0026292,570
€0.00260.00000.0%€0.0026€0.0028€0.0026124,644
€0.0026-0.0002-7.1%€0.0028€0.0028€0.00261,133,367
€0.0028-0.0002-6.7%€0.0032€0.0032€0.0026381,834
€0.0030+0.0004+15.4%€0.0026€0.0036€0.00264,631,424
€0.00260.00000.0%€0.0026€0.0028€0.0026111,270
€0.0026-0.0002-7.1%€0.0024€0.0028€0.0024281,105
€0.00280.00000.0%€0.0028€0.0028€0.002846,500
€0.00280.00000.0%€0.0028€0.0028€0.0028100,000

Splits

1 split · EURONEXT:OXUR · every price before a split is adjusted for it

DayRatioWhat
1-for-10000Consolidation
Ticker
gettex:TG40
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
gettex
Currency
EUR

What changed lately

Latest news

All Oxurion NV news

Oxurion NV on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
15 in the last 12 months · 15 in all · newest Sep 30, 2026 · oldest 2025
Decks
9 decks · latest Jun 7, 2022

Where Oxurion NV is listed

ListingExchangeCountryCurrency
Euronext:OXUR · Home listingEuronextBelgiumEUR
LSE:0G99LSEUnited KingdomEUR
LS Exchange:A40H8HLS ExchangeGermanyEUR
gettex:TG40 · This pagegettexGermanyEUR
Lang & Schwarz:A40H8HLang & SchwarzGermanyEUR
Frankfurt:TG40FrankfurtGermanyEUR
Stuttgart:TG40StuttgartGermanyEUR
Aquis:OXURBAquisUnited KingdomEUR
Aquis:OXURBAquisUnited KingdomEUR
Turquoise:OXURBTurquoiseUnited KingdomEUR

Valuation

EV/sales 21.1× against a median of 1.3×: 8th lowest of 9 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
€11.71M EUR
P/E
Loss
EV/sales
21.1×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
87.8%
Operating margin
−653.9%
Net margin
−671.7%
Debt to equity
Negative equity
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Oxurion NV · EURONEXT:OXURUS$254,615US$12.85Mn/a21.1×n/an/a−671.7%n/an/a
Innovotech Inc. · TSXV:IOTUS$2.66MUS$2.51Mn/a1.0×n/a1.5×−21.1%0.1×0.39
Qlife Holding AB · OMXSTO:QLIFEUS$2.49MUS$2.88Mn/a34.1×n/a9.6×n/a3.1×n/a
Physiomics PLC · LSE:PYCUS$2.46MUS$1.91Mn/a1.6×n/a3.6×−74.1%0.0×n/a
20/20 BioLabs, Inc. · NASDAQ:AIDXUS$2.10M−US$1.01Mn/a−0.5×n/a3.4×−317.8%0.9×1.41
Bluejay Diagnostics, Inc. · NASDAQ:BJDXUS$1.90M−US$5.43Mn/an/an/a0.3×n/a0.0×1.71
Accustem Sciences Inc · OTC:ACUTUS$1.90MUS$1.88Mn/an/an/an/an/an/a0.19
InVitro International · OTC:IVROUS$1.87MUS$644,26029.6×0.8×14.0×1.1×8.2%0.0×0.17
Co-Diagnostics, Inc. · NASDAQ:CODXUS$1.36MUS$2.21Mn/a2.6×n/a0.1×n/a0.2×2.16
Prostatype Genomics AB · OMXSTO:PROGENUS$1.36MUS$1.32Mn/a13.3×n/a2.1×n/a0.0×n/a
Virax Biolabs Group Limited · NASDAQ:VRAXUS$446,402−US$5.66Mn/a−455×n/a0.1×n/a0.1×1.38
Median of the othersUS$1.90MUS$1.60M29.6×1.3×14.0×1.5×−47.6%0.1×1.38

Team and board

Officers

OfficerRole
Pascal GhosonCEO & CFO, Executive Director

Board

DirectorRole
Charles Paris de BollardièreChairman of the Board
James HartmannIndependent Non-Executive Director
Nelly SouleymaneIndependent Non-Executive Director
Pascal GhosonCEO & CFO, Executive Director

Events

QuarterResultsShare move
Quarter to Sep 30, 2025Nov 28, 2025−1.9%
Q2 2025Sep 30, 2025+4.2%
Quarter to Mar 31, 2025Apr 11, 20250.0%
Q4 2024Mar 31, 2025−20.0%
Quarter to Sep 30, 2024Nov 29, 2024−6.5%
Q2 2024Sep 30, 2024−12.8%
Quarter to Mar 31, 2024Apr 15, 2024 · After close0.0%
Quarter to Sep 30, 2023Oct 20, 2023−30.0%
Q2 2023Sep 29, 2023 · After close+8.3%
Q1 2023May 4, 2023−4.0%
All 19 quarters
QuarterResultsShare move
Q4 2022Mar 24, 2023 · After close+2.0%
Q3 2022Oct 21, 2022−30.1%
Q2 2022Sep 7, 2022 · Before open−11.2%
Quarter to Mar 31, 2022May 12, 2022+2.1%
Q4 2021Mar 25, 2022 · After close+5.1%
Q3 2021Oct 14, 2021+0.4%
Q2 2021Sep 9, 2021 · After close0.0%
Q1 2021May 6, 2021−2.0%
Q4 2020Mar 17, 2021 · After close+1.2%

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (June 2022)Technical12 slidesJun 7, 2022
Investor Presentation (May 2022)Investor deck21 slidesMay 2022
Investor Presentation (February 2022)Investor deck45 slidesFebruary 2022
Investor Presentation (January 2022)Investor deck32 slidesJanuary 2022
Investor Presentation (November 2021)Investor deck35 slidesNovember 2021
Angiogenesis, Exudation, and Degeneration 2020Conference19 slidesFeb 8, 2020
Investor Presentation (September 2019)Investor deck43 slidesSeptember 2019
FLORetina 2019Conference16 slidesJune 2019
ThromboGenics — Investor Presentation (May 2017)Investor deck46 slidesMay 2017

Open Decks

Financings

RaiseDate
Convertible bonds
Announced: convertible
Buyers: Atlas Capital Markets (Subscription agreement for convertible bonds totalling €30 million in 12 tranches of €2.5 million)
Use of proceeds: Launch investment strategy in digital assets, specifically Bitcoin and Ethereum
Dec 1, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue555.0K3.00K263.0K595.0K1.13M2.08M3.95M5.32M5.81M7.10M
Cost of revenue68.0K43.0K159.0K513.0K612.0K550.0K5.03M3.35M2.58M6.88M
Gross profit487.0K-40.0K104.0K82.0K516.0K1.53M-1.09M1.97M3.23M224.0K
Research and development1.85M1.24M9.99M16.0M20.7M22.1M23.7M29.6M24.0M24.7M
Selling, general and administrative1.92M2.01M2.82M5.98M7.15M5.49M6.41M6.35M6.23M6.52M
Operating income-3.63M382.0K-12.1M-22.9M-28.5M-28.6M-37.9M-39.2M-29.5M-34.2M
Depreciation and amortization68.0K142.0K268.0K353.0K77.0K194.0K2.77M3.63M3.83M7.68M
EBITDA-3.56M524.0K-11.8M-22.6M-28.4M-28.4M-35.1M-35.6M-25.6M-26.6M
Interest expense9.00K218.0K7.27M9.38M1.27M408.0K55.0K24.0K31.0K36.0K
Income before tax-3.70M122.0K-19.0M-31.7M-29.6M-28.6M-52.1M-38.8M22.6M-60.4M
Income tax10.0K3.00K3.00K7.00K3.00K017.0K10.0K14.0K-22.0K
Net income-3.73M119.0K-19.0M-31.7M-29.2M-28.0M-51.8M-38.5M22.8M-60.3M
Earnings per share, basic-0.130.09-114.82-0.37-0.77-0.75-13,535.39-10,058.566,226.23-16,483.74
Earnings per share, diluted-0.37-0.77-0.75

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents430.0K455.0K1.62M3.50M9.74M24.5M42.5M64.7M56.2M58.3M
Short-term investments50.0K95.0K247.0K288.0K10.4M20.5M49.6M21.8M
Receivables381.0K2.36M1.01M825.0K974.0K1.41M2.29M2.74M2.63M5.18M
Inventory05.00K60.0K85.0K20.0K1.04M2.20M2.61M
Current assets1.81M3.58M2.74M7.11M13.4M27.1M57.0M91.1M124.3M91.4M
Property, plant and equipment57.0K99.0K120.0K230.0K2.55M614.0K991.0K1.74M
Goodwill182.0K0000
Total assets3.83M5.70M6.55M12.0M18.9M34.3M65.0M114.9M150.4M121.6M
Accounts payable2.54M4.52M4.94M5.04M4.98M4.38M4.72M5.05M3.30M5.94M
Current liabilities16.2M16.6M19.6M12.3M10.9M7.69M10.4M9.55M17.1M11.8M
Long-term debt03.23M8.43M0
Total debt11.4M11.3M12.3M8.02M12.1M1.10M2.23M
Total liabilities16.5M16.8M19.7M16.6M20.0M9.24M11.7M9.55M17.1M11.8M
Shareholders' equity-12.9M-11.1M-13.2M-4.58M-1.08M25.2M53.2M104.9M132.6M109.8M
Shares outstanding28.0M1.27M165.2K8.50K3.84K3.83K3.83K3.83K3.66K3.66K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-1.71M-2.07M-9.77M-19.4M-27.0M-27.1M-31.1M-31.1M26.3M-20.3M
Capital spending00-1.00K-59.0K-32.0K-119.0K-133.0K-195.0K-246.0K-572.0K
Free cash flow-1.71M-2.07M-9.77M-19.4M-27.0M-27.2M-31.2M-31.3M26.0M-20.9M
Cash from investing-270.0K84.0K72.0K111.0K407.0K10.1M10.0M29.1M-27.6M-15.1M
Cash from financing1.95M815.0K7.82M13.0M11.8M-931.0K-843.0K84.0K9.99M-6.00K
Share buybacks92.0K10.0M
Change in cash-25.0K-1.17M-1.87M-6.27M-14.8M-17.9M-22.2M-1.52M7.92M-35.1M

Open Financials

Cap table

Built by 6ix from Oxurion NV’s releases · as of Dec 1, 2025

Common shares
232,004,731
Fully diluted
232,004,731

Fully diluted

LineShares
Common shares232,004,731

Share count over time

CountShares
Nov 22, 2026232,004,731

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles Paris de BollardièreChairman of the Board · Since at least Sep 30, 2026
James HartmannIndependent Non-Executive Director · Since at least Nov 6, 2026
Nelly SouleymaneIndependent Non-Executive Director · Since at least Nov 6, 2026
Pascal GhosonCEO & CFO, Executive Director · Since at least Sep 30, 2026

Open People

Log in to ask 6ix AI your own questions about Oxurion NV.